Joshua D. Schein
Director Ejecutivo en Lev Development Corp. .
Cargos activos de Joshua D. Schein
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Lev Development Corp. | Director Ejecutivo | 01/07/2003 | - |
Prism Venture Management LLC
 Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Inversor de Capital Privado | - | - |
Historial de carrera de Joshua D. Schein
Antiguos cargos conocidos de Joshua D. Schein.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SIGA TECHNOLOGIES, INC. | Presidente | 01/12/1995 | 01/04/2001 |
| Secretario Corporativo | 01/12/1995 | 01/04/2001 | |
| Virologix Corp. | Director/Miembro de la Junta | 01/01/1996 | 01/08/1998 |
| Corporate Officer/Principal | 01/01/1996 | 01/08/1998 | |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Director/Miembro de la Junta | 01/12/1995 | 01/06/1998 |
| Josephthal & Co (Broker) | Corporate Officer/Principal | 01/01/1994 | 01/01/1995 |
| HEMOxymed, Inc. | Corporate Officer/Principal | - | - |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Fundador | 28/05/2010 | - |
| Corporate Officer/Principal | 01/05/2003 | 28/05/2010 | |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Director/Miembro de la Junta | 01/06/1996 | 01/09/1998 |
| Corporate Officer/Principal | 01/06/1996 | 01/09/1998 | |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Joshua D. Schein.
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Brandeis University | Undergraduate Degree |
| Yeshiva University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 13 |
Operativa
| Corporate Officer/Principal | 5 |
| Director/Board Member | 3 |
| President | 2 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 4 |
| Finance | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SIGA TECHNOLOGIES, INC. | Health Technology |
| Empresas privadas | 8 |
|---|---|
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Health Technology |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| Virologix Corp. | Health Technology |
| Josephthal & Co (Broker) | Finance |
| Lev Development Corp. | |
| HEMOxymed, Inc. | Health Technology |
Prism Venture Management LLC
Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Finance |
- Bolsa de valores
- Insiders
- Joshua D. Schein
- Experiencia